A subpopulation of human calreticulin (CR) molecules that is reactive with human Ro/SS-A autoimmune sera was identified in a nucleic acid- enriched Wil-2 cell fraction derived by anion exchange column chromatography. Further resolution of this fraction by gel filtration size separation demonstrated that the appearance of CR (true mol. weight 46 kD) coincided with the emergence of Ro/SS-A ribonucleoprotein (mol. weight> 250 kD) antigenic activity and increasing 260 nm ultraviolet absorbance. This high nucleic acid fraction could be further partitioned into four small RNA-containing Ro/SS-A antigenic subfractions by a second passage over the anion exchange column. CR was enriched in one subfraction and present in the other three subfractions as well. No CR was found in the RNA-free fraction of the repartition eluate. These results represent the first direct demonstration that CR, a high-affinity calcium binding protein, exists in a form that is directly associated with all four varieties of native, human Ro/SS-A ribonucleoprotein particles (hY1-5).
Michalak M., Milner RE, Burns K. and Opas M.Calreticulin. Biochem J1992; 285: 681-692.
2.
Michalak M (ed). R.G. Landes Co.: Molecular Biology Intelligence Unit, Austin, 1996.
3.
Sontheimer RD et al. The unveiling of calreticulin-A clinically relevant tour of modem cell biology. J Invest Med1995; 43: 362-370.
4.
Sontheimer RD , Lieu T-S. and Capra JDThe diverse functional repertoire of calreticulin, a new human autoantigen. The Immunologist1993; 1: 155-160.
5.
Sontheimer RD et al. Calreticulin and autoimmunity. In: Michalak M. (ed). Calreticulin . R.G. Landes Co.: Molecular Biology Intelligence Unit , Austin, 1996, 117-139.
6.
Lieu TS, Newkirk MM, Capra JD and Sontheimer RDMolecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide. J Clin Invest1988; 82: 96-101.
7.
Lieu TS et al. A major autoepitope is present on the amino terminus of a human SS-A/Ro polypeptide. J Autoimmunity1989; 2: 367-374.
8.
McCauliffe DP et al. Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen. J Clin Invest1990; 85: 1379-1391.
9.
McCauliffe DP et al. A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchoceral RAL-1 antigen and an aplysia 'memory molecule'. J Clin Invest1990; 86: 332-335.
10.
Conrad ME, Umbreit JN and Moore EGRat duodenal iron-binding protein mobiterrin is a homologue of calreticulin . Gastroenterology1993; 104: 1700-1704.
11.
Atreya CD, Pogue GP, Singh NK and Nakhasi HLRole of calreticulin in rubella virus replication. In: Michalak M (ed). Calreticulin. R.G. Landes Co.: Molecular Biology Intelligence Unit, Austin, 1996, 89-115.
12.
Rokeach LA et al. Characterization of the autoantigen calreticulin. J Immunol1991; 147: 3031-3039.
13.
Khalife J. et al. Cloning of the gene encoding a Schistosoma mansoni antigen homologous to human Ro/SS-A autoantigen. Mol Biochem Parasitol1993; 57: 193-202.
14.
Routsias JG et al. Calreticulin synthetic peptide analogues: antipeptide antibodies in autoimmune rheumatic diseases. Clin Exp Immunol1993; 91: 437-441.
15.
Boehm J., Orth T., Van Nguyen P. and Sling H.D.Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and Grp94, but calreticulin is not the Ro/SS-A antigen . Eur J Clin Invest1994; 24: 248-257.
16.
Nakhasi HL et al. Specific high affinity of host cell proteins to the 3' region of rubella virus RNA. New Biologist1990; 2: 255-264.
17.
Nakhasi HL, Cao XQ, Rouault TA and Liu TYSpecific binding of host cell proteins to the 3'- terminal serum loop structure to rubella virus negative-strand RNA. J Virol1991; 65: 5961-5967.
18.
Singh NK, Atreya CD and Nakhasi HLIdentification of calreticulin as a rubella virus RNA binding protein . Proc Natl Acad Sci USA1994; 91: 12770-12774.
19.
Nakhasi HL et al. Identification and characterization of host factor interactions with cis-acting elements of rubella virus RNA. Arch Virol1994.
20.
Atreya CD, Singh NK and Nakhasi HLThe rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain. J Virol1995; 69: 3848-3851.
Cheng ST et al. Calreticulin binds hYRNA and the 52 kD polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J Immunol1996; 156: 4484-4491.
23.
Sontheimer RD et al. Clinical correlations of autoantibodies to a recombinant, hYRNA-binding form of recombinant human calreticulin. J Invest Dermatol1996; (Abstract).
24.
Lieu T-S., Jiang M., Steiger-wald JC and Tan EMIdentification of the SS-A/RA intracellular antigen with autoimmune sera. J Immunol Methods1984; 71: 217-228.
25.
Tan EM et al. Reference reagents for antinuclear antibodies. Arthritis Rheum1988; 31: 1331 (Letters).
26.
Laemeli UKClevage of structural proteins during the assembly of the bacteriophage T4 . Nature1970; 227: 680-685.
27.
Towbin HT, Staehelin T. and Gordon J.Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA1979; 79: 4350-4354.
28.
Rader MD et al. The heterogeneity of the Ro/SS-A antigen: different molecular forms in lymphocytes and red blood cells. J Clin Invest1989; 83: 1293-1298.
29.
Lieu T-S., Newkirk M., Capra JD and Sontheimer RDMolecular characterization of human Ro/SS-A antigen: amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity to a corresponding synthetic peptide. J Clin Invest1988; 82: 96-101.
30.
Boire G. and Craft J.Biochemical and immunological heterogeneity of the Ro ribonucleoprotein particles. Analysis with sera specific for the RohY5 particle. J Clin Invest1989; 84: 270-279.
31.
Boire G. and Craft J.Human Ro ribonucleoprotein particles: Characterization of native structure and stable association with the La polypeptide. J Clin Invest1990; 85: 1182-1190.
32.
Boire G., Lopez-Longo F-J., Lapointe S. and Ménard H-A.Sera from patients with autoimmune disease recognize conformational determinants on the 60 kD Ro/SS-A protein. Arthritis Rheum1991; 34: 722-730.
33.
Itoh Y. and Reichlin M.Autoantibodies to the Ro/SS-A antigen confirmation dependent. 1: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity1992; 14: 57-65.
34.
Zappi E. and Sontheimer R.Clinical relevance of antibodies to Ro/SSA and La/SS-B in subacute cutaneous lupus erythematosus and related conditions. Immunol Invest1993; 22: 189-203 (Review).
35.
Lux FA et al. Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambdaRAL-1 antigen of Onchocerca volvulus. J Clin Invest1992; 89: 1945-1951.
36.
Khanna NC and Waismann DMDevelopment of a radioimmunoassay for quantitation of calregulin in bovine tissues. Biochemistry1986; 25: 1078-1082.
37.
Rojiani MV, Finlay BB, Gray V. and Dedhar S.In vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin α subunits. Biochemistry1991; 30: 9859-9866.
38.
Eggleton P. et al. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin Immunol Immunopathol1994; 72: 405-409.
39.
Jethmalani SM, Henle KJ and Kaushal GPHeat shock induced prompt glycosylation. Identification of P-SG67 as calreticulin. J Biol Chem1994 ; 269: 23603-23609.
40.
Treves S., Zorzato F. and Pozzan T.Identification of calreticulin isoforms in the central nervous system . Biochemical Journal1992; 287: 579-581.
41.
Liu N., Fine RE and Johnson RJComparison of cDNAs from bovine brain coding for two isoforms of calreticulin . Biochemica et Biophysica Acta1993; 1202: 70-76.
42.
Pogue GP, Cao XQ, Singh NK and Nakhasi HL5' sequences of rubella virus RNA stimulate translation of chimeric RNA's and specifically interact with two host encoded proteins. J Virol1993; 67: 7106-7117.
43.
Meerovitch K. et al. La autoantigen enhances and corrects aberrant translation of polio virus RNA in reticulocytic lysate. J Virol1993; 67: 3798-3807.
44.
Svitkin YV et al. Internal translation initiation on poliovirus RNA: Further characterization of La function in poliovirus translation in vitro. J Virol1994; 68: 1544-1550.
45.
Chang Y-N. et al. Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol1994; 68: 7008-7020.
46.
O'Banion MK , Winn VD, Settleman J. and Young DAGenetic definition of a new bovine papilloma virus Type I open reading frame, E5B, that encodes a hydrophobic protein involved in altering host-cell protein. J Virol1993 ; 67: 3427-3434.
47.
Nakhasi HL et al. Identification and characterization of host factor interactions with cis-acting elements of rubella virus RNA. Arch Virol1994; 136 (Suppl. 9): 255-267.
48.
Newkirk MM and Tsoukas C.Effect of ultraviolet irradiation on selected host cell proteins including Ro/SS-A and Epstein-Barr virus in cultured lymphoblastoid cell lines. J Autoimmunity1992; 5: 511-525.
49.
Kawashima T. et al. Regulation of expression of the polypeptide constituents of the Ro autoantigen complex in transformed human epidermal keratinocytes. Lupus1994; 3: 493-500.
50.
Zhu J.Cytomegalovirus infection induces expression of 60 kD/Ro antigen on human keratinocytes. Lupus1995; 4: 396-406.
51.
Hanks SK, Quinn AM and Hunter T.The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science1988; 241: 41-52.
52.
Malhotra R. et al. Structure and homology of the human C1q receptor (collectin receptor). Immunology1993; 78: 341-348.
53.
Chen A. et al. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol1994; 153: 1430-1440.
